Legal status · United States
Is Methylene Blue legal in the United States?
Yes. Methylene Blue is an approved medicine in the United States, classified as "Prescription drug for methemoglobinemia; 'supplement' products are unapproved". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Methylene Blue in the United States at a glance
| Classification | Prescription drug for methemoglobinemia; 'supplement' products are unapproved |
|---|---|
| FDA approval status | FDA-approved for methemoglobinemia only (ProvayBlue); other uses are off-label or unapproved |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Methylene Blue profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Methylene Blue for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Methylene Blue is
An FDA-approved antidote for methemoglobinemia that biohackers take at low doses for mitochondrial energy and focus; the cognitive evidence is thin and it is a monoamine oxidase inhibitor with documented fatal interactions with antidepressants.
Methylene blue is a century-old dye and drug. At low doses it can act as an alternative electron carrier in mitochondria, and small imaging studies in healthy adults showed changes in brain activity during memory tasks.
Mechanism: Redox cycling that shuttles electrons within the mitochondrial respiratory chain, plus reversible inhibition of monoamine oxidase A and nitric-oxide synthase.
Regulatory history: FDA-approved for methemoglobinemia only (ProvayBlue); other uses are off-label or unapproved
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Methylene Blue at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Methylene Blue in other countries
Frequently asked questions
Is Methylene Blue legal in the United States?
Yes. Methylene Blue is an approved medicine in the United States, classified as "Prescription drug for methemoglobinemia; 'supplement' products are unapproved". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Can I buy Methylene Blue in the United States?
Only with a prescription. Methylene Blue is classified as "Prescription drug for methemoglobinemia; 'supplement' products are unapproved" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Methylene Blue FDA approved?
Yes. FDA status: FDA-approved for methemoglobinemia only (ProvayBlue); other uses are off-label or unapproved. Current US classification: "Prescription drug for methemoglobinemia; 'supplement' products are unapproved". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Methylene Blue live on its compound profile.
Methylene Blue profileThis page is general information about the regulatory status of Methylene Blue in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.